UPDATE: TransMedics Group (TMDX) Prices 5M Share Common Offering at $14/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. SPY
5. META
6. MSFT
7. USO
8. AMD
9. GMAB
10. ATH

Go back to UPDATE: TransMedics Group (TMDX) Prices 5M Share Common Offering at $14/Sh

TransMedics Group (TMDX) Announces Proposed $60M Public Offering of Common Stock

May 26, 2020 7:14 AM EDT

TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today the commencement of a proposed public offering of $60 million of its shares of common stock. All of the shares will be offered by TransMedics. TransMedics also expects to grant the underwriters a 30-day option to purchase... More

TransMedics Group (TMDX) Reports U.S. Pivotal OCS Liver PROTECT Trial Achieved Primary Clinical Objectives

May 26, 2020 7:10 AM EDT

TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported positive top-line results from its U.S. Pivotal OCS Liver PROTECT Trial. The trial achieved its primary clinical objectives by meeting both the primary and secondary effectiveness and safety endpoints. For... More